glp 1 medications covered by blue cross blue shield of Massachusetts will stop covering popular GLP-1 weight-loss drugs like Ozempic and Wegovy starting January 1, 2026. The decision comes as the costs for these have IBX members face GLP-1 drug

PT-141 Third-Party Tested COA Available PT-141 10 mg is a synthetic cyclic heptapeptide used in laboratory research for melanocortin receptor signaling and binding studies

FDA has not issued a final rule RUO sourcing status: Unaffected

10.1074/jbc.M202919200 J

Morgan Stanley estimated in 2024 that employer GLP-1 coverage generates USD 8,200 in annual healthcare cost savings per successfully treated employee with obesity generating positive ROI within 3 to 5 years

Some of the earlier GLP-1 compounds appear to access the brain more readily than semaglutide, Kanoski says

Similarly, symptoms suggestive of gallbladder disease such as right upper quadrant pain, particularly after eating fatty foodsshould be evaluated, as rapid weight loss associated with GLP-1 treatment can increase the risk of gallstone formation